Business Economy


JB Pharma net up 16 percent to Rs 175 crore in Q2

New Delhi, Nov 6 (UNI) JB Chemicals & Pharmaceuticals Limited (JB Pharma) on Wednesday announced second quarter (July-September) financial performance and said its Profit After Tax grew 16 percent y-o-y to Rs 175 crore versus Rs 151 crore in the same quarter of last financial year.
JB Pharma recorded Revenue of Rs 1001 crore in the second quarter of FY25 registering growth of 13 percent from Rs 882 crores in Q2 FY24, the company said in a release.
Commenting on the financial results, Nikhil Chopra, CEO and Whole time Director, JB Pharma mentioned, “We maintained a healthy pace of growth in Q2, achieving Rs 1,000 crore revenue for the quarter. EBITDA margins at 28 percent are at the higher end of our guidance range, given a favourable product mix and cost optimization initiatives.”
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth. The company has steadily driven strong volume growth for its large brands, including the acquired portfolios.
“On the international front, our formulations business performed well in Q2 and CDMO division growth will pick up in H2 as we come out of a seasonally muted Q2. JB has consistently delivered a strong revenue and margin growth. We are confident of maintaining this positive traction towards our operating and strategic goals for both this year and beyond. As we chart our future, we remain focused on making the organisation progressive and future ready,” Chopra added.
For the first six months of fiscal 2024-25, the company said that it recorded revenue of Rs 2005 crore as compared to Rs 1778 crores, registering growth of 13 percent. Profit after Tax grew 20 percent to Rs 351 crore as against Rs 293 crore in H1 FY24.
UNI SKB CS1920
More News
Sensex tanks by 601 03 points

Sensex tanks by 601 03 points

23 Jun 2025 | 10:16 AM

Mumbai, June 23 (UNI) The BSE Sensex on Monday tanked by 601.04 points to 81,807.13 in early trade, influenced by Asian market trends as investors closely monitor potential retaliatory actions by Iran following a US attack on its nuclear site, traders said.

see more..

NLC India's renewable arm wins 500 MWh battery energy storage project in TN

23 Jun 2025 | 2:57 AM

Hyderabad, June 22 (UNI) NLC India Renewables Limited (NIRL), a wholly owned subsidiary of NLC India Limited (NLCIL) on Sunday said it has been awarded 500 MWh Battery Energy Storage System (BESS) project by Tamil Nadu Green Energy Corporation Limited (TNGECL).

see more..

NLCIL bags 500 MWh battery storage project

22 Jun 2025 | 4:41 PM

Bengaluru, June 22 (UNI) NLC India Renewables Limited (NIRL), the green energy arm of NLC India Limited (NLCIL), has been awarded a major Battery Energy Storage System (BESS) project by the Tamil Nadu Green Energy Corporation Limited (TNGECL), marking a significant step forward in India’s clean energy transition.

see more..
EEPC India suggests 3-year moratorium for MSMEs from EU's carbon tax

EEPC India suggests 3-year moratorium for MSMEs from EU's carbon tax

22 Jun 2025 | 12:38 PM

Kolkata, June 22 (UNI) Engineering Exports Promotion Council of India ( EEPC India) has suggested the Centre for a three-year moratorium for Indian MSMEs from the carbon tax proposed by the European Union (EU) under Carbon Border Adjustment Mechanism (CBAM), which would come into force in January 2026.

see more..
Telangana: Singareni to set up Rs 3,000 cr pumped storage power plant at Medipalli mine

Telangana: Singareni to set up Rs 3,000 cr pumped storage power plant at Medipalli mine

21 Jun 2025 | 10:44 PM

Hyderabad, June 21 (UNI) As part of its business expansion strategy, State-owned Singareni Collieries Company Limited (SCCL), which has already established thermal and solar power plants, is now venturing into an innovative new power generation initiative.

see more..